IH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IH is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading pre-market at 1.7, but the current technical setup is still weak, there is no Intellectia buy signal, and the latest quarter shows declining revenue and net income. The only supportive point is a possible short-term month-ahead rebound in the stock trend data, but that is not enough to override the lack of clear momentum, neutral sentiment, and deteriorating fundamentals. My direct view: do not buy now; hold off.
The technical picture is mixed to bearish. MACD histogram is slightly positive at 0.00135 but is contracting, which weakens the bullish case. RSI_6 at 41.984 is neutral and not showing oversold strength. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which indicates the longer-term trend remains down. Price is near pivot 1.714, with resistance at 1.787 and 1.831 and support at 1.641 and 1.597. In short, the stock is below a strong uptrend signal and lacks a convincing breakout setup.
The company filed its annual report on Form 20-F for 2025, which supports transparency and compliance. iHuman continues to position itself around tech-powered educational products for children, which preserves a long-term business theme. Stock trend data suggests a possible 7.44% move higher over the next month based on similar candlestick patterns, though this is not strong enough on its own.
Revenue in 2025/Q4 dropped 18.06% YoY and net income fell 41.81% YoY, showing clear top-line and bottom-line weakness. Gross margin also slipped slightly. Hedge funds and insiders are neutral with no meaningful buying support. There is no recent congress trading data, no significant insider activity, and no AI Stock Picker or SwingMax signal today. The near-term stock pattern also shows a 70% chance of slight downside in the next day and next week.
In 2025/Q4, iHuman reported revenue of 190.654 million, down 18.06% year over year, and net income of 15.41 million, down 41.81% year over year. EPS rose to 0.29, but that improvement is not enough to offset the weaker revenue and profit trends. Gross margin was 66.85%, slightly lower year over year. Overall, the latest quarter season shows contraction rather than growth.
No analyst rating or price target change data was provided, so there is no evidence of a positive Wall Street revision trend. Based on the available information, the pros view would focus on the company’s education-tech positioning and ongoing compliance, while the cons view is stronger because of declining revenue, weaker net income, bearish moving averages, and no supportive trading signals.
